Available Technology

Recombinant vaccine against Marek’s disease and Newcastle disease

A novel, recombinant dual vaccine against Marek’s disease and Newcastle disease has been developed using reverse genetics technology. This vaccine is safe and stable and can be lyophilized or stored and transported at an amble temperature. Vaccine generation and vaccination methods are included in the invention.

Benefits
• Provides dual protection against Marek’s disease and Newcastle disease
• Eliminates the “cold chain” requirement for Marek’s disease vaccine production, storage, and transportation
• Can be delivered by mass immunization routes (e.g. aerosol, drinking water) to large chicken populations at an extremely low cost

Applications
• Safe, stable and efficacious vaccine to prevent Marek’s disease and Newcastle disease in chickens, and to reduce vaccination and poultry production costs

Internal Laboratory Ref #: 
34.19
Lab Representatives
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin